Conditions: Hepatitis B Virus HBV
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 1053
Healthy volunteers: no

Brief summary:
The purpose of this study is to provide entecavir to participants who have completed another entecavir trial without achieving virologic response or who relapsed during postdosing follow-up.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Entecavir intervention 2: Lamivudine
Intervention descriptions: intervention 1: Tablets, Oral, 1.0 mg, once daily intervention 2: Oral, 100 mg, daily

Protocol document: